Hello, Guest
Login
Sign Up
 
 

Best Hot Stocks for Investor to Invest in ( AMD, CSCO, JPM, MRK )

HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.

 
 
Repost This

Los Angelas, CA -- (SBWIRE) -- 10/03/2012 -- Advanced Micro De (NYSE:AMD) is very active today and traded between $3.17 - 3.41 with total traded volume of 27052836 shares. At a current price of 3.27, AMD is -0.01 - -0.30% from the previous close of $3.28. Moreover, At Current Market Price, AMD is in distance of -12.64% from its 50-day Moving Average price of $3.7433 and -41.62% from its 200-day Moving Average price of $5.6009. Advanced Micro Devices, Inc. (NYSE:AMD) has recently launched second-generation AMD A-Series APUs. In the last trading session, the stock’s price moved -44.57% below their 200 day moving average, changing hands as low as $3.26 per share. The stock is currently trading -15.55% down their SMA 50. The worst hit in its 52 week range is $3.22 per share, with $8.35 being the 52 week best price, which compares with a latest closing price of $3.28. The Beta of this stock is 2.22.

Get Your Free Analyst Report On Amd From Here:

Cisco Systems, In (NasdaqNM:CSCO) are trading at $18.87 and is -0.61% from its 50-day Moving Average price of $18.9866 and +4.14% from its 200-day Moving Average price of $18.1194. The average trading volume is 40936100 shares and its market capitalization is $99.823B. Cisco Systems, Inc. (NASDAQ:CSCO) has recently released a set of security solutions designed to keep data centers in Nigeria safe against threats they face in shifting towards more consolidated and virtualized environments, while also enabling businesses to benefited from new cloud-based models. While trading at volume lower than average, the stock fell -0.29% yesterday. Its previous 52-week high was $21.30 and moved up 22.21% over the same period, trading at a volume of 37.48 million. Shares have dropped -9.38% over the trailing 6 months. The stock is currently trading 5.30% above its SMA 50 and 3.23% above its SMA 200.

Get Your Free Analyst Report On CSCO From Here:

JP Morgan Chase & (NYSE:JPM) is -0.05 - -0.12% from the previous close of $40.97. It traded between $40.56 - 41.24 with total traded volume of 26946068 shares. Keep a close eye on JPM, as the stock has been showing unusual moves over the past weeks. At Current market price, JPM has recovered +44.70% from its 52-week Low of 28.28 and has Pulled back -11.98% from its 52-week high of 46.49. JPMorgan Chase & Co. (NYSE:JPM) estimates show that even during the strongest stock rally since 2009, the equities-trading units of Wall Street banks are seeing little help as sinking volume and the thin margins already in place could render their annual performance the worst in six years. Third quarter equities-trading revenue is likely to have fallen by 14 percent year-over-year from 2011, which would mark the fifth consecutive drop of more than 8 percent, according to Bloomberg.

Get Your Free Analyst Report On JPM From Here:

Merck & Company, (NYSE:MRK) reported EPS of 2.19. For the Current Fiscal year, the company is expected to report EPS of 3.81. For the Next Quarter and Next Year, the company is expected to report EPS of 0.85 and 3.72 respectively. At Current Market Price, MRK is in distance of +3.24% from its 50-day Moving Average price of $44.0409 and +11.03% from its 200-day Moving Average price of $40.9525.Merck & Co. (NYSE:MRK) along with Ablynx, announced a collaboration through a subsidiary to develop and commercialize Nanobody candidates directed towards a voltage gated ion channel with the option to develop and commercialize a Nanobody to a second target. Through its terms, Merck obtains exclusive global rights to Nanobodies against the selected target with an option for similar rights to a second target. The firm will pay Ablynx a €6.5 million upfront payment and a €2 million fee for research funding. Also, Ablynx could receive as much as € 448 million in research, regulatory and commercial milestone payments linked with the progress of multiple candidates, along with tiered royalties on any products derived from the collaboration.

Get Your Free Analyst Report On MRK From Here:

Disclaimer:
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com